Regulation of sialic acid O-acetylation in human colon mucosa

Verfasser / Beitragende:
[Y. Shen, J. Tiralongo, G. Kohla, R. Schauer]
Ort, Verlag, Jahr:
2004
Enthalten in:
Biological Chemistry, 385/2(2004-02-05), 145-152
Format:
Artikel (online)
ID: 378893165
LEADER caa a22 4500
001 378893165
003 CHVBK
005 20180305123500.0
007 cr unu---uuuuu
008 161128e20040205xx s 000 0 eng
024 7 0 |a 10.1515/BC.2004.033  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/BC.2004.033 
245 0 0 |a Regulation of sialic acid O-acetylation in human colon mucosa  |h [Elektronische Daten]  |c [Y. Shen, J. Tiralongo, G. Kohla, R. Schauer] 
520 3 |a The expression of O-acetylated sialic acids in human colonic mucins is developmentally regulated, and a reduction of O-acetylation has been found to be associated with the early stages of colorectal cancer. Despite this, however, little is known about the enzymatic process of sialic acid O-acetylation in human colonic mucosa. Recently, we have reported on a human colon sialate 7(9)-O-acetyltransferase capable of incorporating acetyl groups into sialic acids at the nucleotidesugar level [Shen et al., Biol. Chem. 383 (2002), 307317]. In this report, we show that the CMP-N-acetyl-neuraminic acid (CMPNeu5Ac) and acetyl-CoA (AcCoA) transporters are critical components for the O-acetylation of CMPNeu5Ac in Golgi lumen, with specific inhibition of either transporter leading to a reduction in the formation of CMP-5-Nacetyl-9-O-acetylneuraminic acid (CMP-Neu5,9Ac2). Moreover, the finding that 5-Nacetyl-9-O-acetylneuraminic acid (Neu5,9Ac2) could be transferred from neo-synthesised CMP-Neu5,9Ac2 to endogenous glycoproteins in the same Golgi vesicles, together with the observation that asialofetuin and asialo-human colon mucin are much better acceptors for Neu5,9Ac2 than asialo-bovine submandibular gland mucin, suggests that a sialyltransferase exists that preferentially utilises CMPNeu5,9Ac2 as the donor substrate, transferring Neu5,9Ac2 to terminal Galβ1,3(4)R- residues. 
540 |a Copyright © 2004 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Biochemistry  |2 nationallicence 
690 7 |a Molecular biology  |2 nationallicence 
690 7 |a Cellular biology  |2 nationallicence 
700 1 |a Shen  |D Y.  |4 aut 
700 1 |a Tiralongo  |D J.  |4 aut 
700 1 |a Kohla  |D G.  |4 aut 
700 1 |a Schauer  |D R.  |4 aut 
773 0 |t Biological Chemistry  |d Walter de Gruyter  |g 385/2(2004-02-05), 145-152  |x 1431-6730  |q 385:2<145  |1 2004  |2 385  |o bchm 
856 4 0 |u https://doi.org/10.1515/BC.2004.033  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/BC.2004.033  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Shen  |D Y.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Tiralongo  |D J.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Kohla  |D G.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Schauer  |D R.  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biological Chemistry  |d Walter de Gruyter  |g 385/2(2004-02-05), 145-152  |x 1431-6730  |q 385:2<145  |1 2004  |2 385  |o bchm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter